Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. [electronic resource]
Producer: 20180530ISSN:- 1098-6596
- Animals
- Anti-Bacterial Agents -- therapeutic use
- Antimicrobial Cationic Peptides -- biosynthesis
- Autophagy-Related Protein 5 -- biosynthesis
- Beclin-1 -- biosynthesis
- Drug Synergism
- Female
- Glutamate-Cysteine Ligase -- biosynthesis
- Glutathione Reductase -- biosynthesis
- Humans
- Interferon-gamma -- biosynthesis
- Interleukin-6 -- biosynthesis
- Macrophages, Alveolar -- immunology
- Mice
- Mice, Inbred C57BL
- Nitric Oxide Synthase Type II -- biosynthesis
- Pneumocystis -- drug effects
- Pneumonia, Pneumocystis -- drug therapy
- Primaquine -- therapeutic use
- Trimethoprim, Sulfamethoxazole Drug Combination -- therapeutic use
- Tumor Necrosis Factor-alpha -- biosynthesis
- Vitamin D -- therapeutic use
- Cathelicidins
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.